ATOS Highlights 2025 Progress in Oncology Trials, Pauses Metastatic Breast Cancer Study, Explores Duchenne Muscular Dystrophy Potential
Atossa Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $5.11
+26% since the alert
$4.05 → $5.11
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS